13F-HR filed by Ikarian Capital, LLC
Ikarian Capital, LLC filed this 13F-HR for the quarter ended 2023-06-30, filed 2023-08-14, with 122 holding rows worth $627,923,144.
- Accession
- 0001420506-23-001546
- Filer
- CIK 1778253
- Filed
- 2023-08-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2023
A holdings report, 122 entries on the cover page, a total value of $627,923,144 stated on the cover page (in dollars after the unit check, H1), rows summing to $627,923,144 with VALUE read as dollars as filed, 13F file number 028-19721. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ACELYRIN INC | 00445A100 | COM | 2,918,426 | $60,995,103 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 132,100 | $51,483,333 | dollars as filed | put |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 1,229,800 | $21,152,560 | dollars as filed | call |
| BIOMEA FUSION INC | 09077A106 | CMN | 936,800 | $20,562,760 | dollars as filed | call |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 826,100 | $20,520,324 | dollars as filed | put |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 826,100 | $20,520,324 | dollars as filed | call |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 250,000 | $17,892,500 | dollars as filed | call |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 38,000 | $14,809,740 | dollars as filed | call |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 122,100 | $13,982,892 | dollars as filed | put |
| Ventyx Biosciences Inc | 92332V107 | Common Stock | 374,100 | $12,270,480 | dollars as filed | put |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 133,800 | $12,189,180 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 133,000 | $12,116,300 | dollars as filed | put |
| Merck & Co.,Inc. | 58933Y105 | COM | 100,000 | $11,538,999 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 490,893 | $11,535,987 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 272,752 | $11,501,952 | dollars as filed | |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 200,000 | $11,228,000 | dollars as filed | put |
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 200,000 | $11,228,000 | dollars as filed | call |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 110,000 | $11,215,600 | dollars as filed | call |
| DISC MEDICINE INC COM | 254604101 | Stock | 240,031 | $10,657,376 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 485,000 | $10,233,500 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 427,417 | $10,223,814 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 100,000 | $8,668,000 | dollars as filed | put |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 475,000 | $8,559,501 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 447,700 | $8,448,099 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 796,300 | $8,257,631 | dollars as filed | put |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 348,200 | $8,085,204 | dollars as filed | put |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 429,686 | $7,390,599 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 140,000 | $6,991,600 | dollars as filed | |
| MARINUS PHARMACEUTICALS INC | 56854Q200 | COM NEW | 611,932 | $6,645,582 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 350,000 | $6,604,500 | dollars as filed | call |
| BIOMEA FUSION INC | 09077A106 | CMN | 286,700 | $6,293,065 | dollars as filed | put |
| IMMUNOVANT INC | 45258J102 | COM | 326,200 | $6,188,014 | dollars as filed | call |
| BIOMEA FUSION INC | 09077A106 | CMN | 275,875 | $6,055,457 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 211,400 | $5,838,868 | dollars as filed | put |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 280,000 | $5,686,800 | dollars as filed | |
| ULTRAGENYX PHARMACEUTICAL IN | 90400D108 | COM | 121,658 | $5,612,084 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 200,000 | $5,524,000 | dollars as filed | call |
| BIOHAVEN LTD | G1110E107 | COM | 225,000 | $5,382,000 | dollars as filed | call |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 228,300 | $5,301,126 | dollars as filed | call |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 135,486 | $5,216,212 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 203,037 | $5,181,504 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 579,390 | $4,826,318 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 68,800 | $4,749,264 | dollars as filed | call |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 130,000 | $4,635,800 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 200,000 | $4,220,000 | dollars as filed | call |
| ARCUS BIOSCIENCES INC | 03969F109 | COM | 200,000 | $4,062,000 | dollars as filed | call |
| LYRA THERAPEUTICS INC | 55234L105 | COM | 978,626 | $4,022,153 | dollars as filed | |
| LONGBOARD PHARMACEUTICALS IN | 54300N103 | COM | 504,253 | $3,701,216 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 300,000 | $3,435,000 | dollars as filed | |
| ALLAKOS INC | 01671P100 | COM | 772,092 | $3,366,321 | dollars as filed | |
| ACUMEN PHARMACEUTICALS INC | 00509G209 | CMN | 654,945 | $3,150,286 | dollars as filed | |
| NOVAVAX INC | 670002401 | COM NEW | 400,000 | $2,972,000 | dollars as filed | put |
| NOVAVAX INC | 670002401 | COM NEW | 400,000 | $2,972,000 | dollars as filed | call |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 315,480 | $2,760,451 | dollars as filed | |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 545,103 | $2,752,770 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 150,000 | $2,580,000 | dollars as filed | put |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 22,100 | $2,530,892 | dollars as filed | call |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 174,510 | $2,457,101 | dollars as filed | |
| ESPERION THERAPEUTICS INC NEW COM | 29664W105 | Stock | 1,705,605 | $2,370,791 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 215,200 | $2,287,576 | dollars as filed | call |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 225,000 | $2,267,999 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 100,000 | $2,090,000 | dollars as filed | call |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 200,163 | $2,075,690 | dollars as filed | |
| KEZAR LIFE SCIENCES INC | 49372L100 | COM | 841,596 | $2,061,910 | dollars as filed | |
| DICE THERAPEUTICS INC | 23345J104 | COM | 43,600 | $2,025,656 | dollars as filed | put |
| BIOVIE INC | 09074F207 | COM | 448,556 | $1,933,276 | dollars as filed | |
| INTERCEPT PHARMACEUTICALS IN | 45845P108 | COM | 160,200 | $1,771,813 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 154,400 | $1,769,424 | dollars as filed | call |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 200,000 | $1,750,000 | dollars as filed | call |
| ELEVATION ONCOLOGY INC COM | 28623U101 | Stock | 1,149,490 | $1,747,225 | dollars as filed | |
| LEGEND BIOTECH CORP | 52490G102 | SPONSORED ADS | 25,000 | $1,725,751 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 63,125 | $1,662,081 | dollars as filed | |
| IMMUNIC INC | 4525EP101 | COM | 650,000 | $1,631,500 | dollars as filed | |
| JASPER THERAPEUTICS INC | 471871103 | COM | 1,125,087 | $1,541,370 | dollars as filed | |
| SCPHARMACEUTICALS INC | 810648105 | COM | 150,000 | $1,528,500 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 192,260 | $1,507,318 | dollars as filed | |
| IMMUNOVANT INC | 45258J102 | COM | 76,000 | $1,441,720 | dollars as filed | put |
| BLUEBIRD BIO INC | 09609G100 | COM | 412,628 | $1,357,545 | dollars as filed | |
| Milestone Pharmaceuticals Inc | 59935V107 | COM | 460,416 | $1,312,186 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 140,000 | $1,260,000 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 10,300 | $1,209,220 | dollars as filed | put |
| FIBROGEN INC | 31572Q808 | COM | 400,000 | $1,080,000 | dollars as filed | call |
| FIBROGEN INC | 31572Q808 | COM | 379,300 | $1,024,110 | dollars as filed | put |
| RENEO PHARMACEUTICALS INC | 75974E103 | COM | 155,819 | $1,022,173 | dollars as filed | |
| PROTAGONIST THERAPEUTICS | 74366E102 | COM | 35,000 | $966,700 | dollars as filed | |
| ARDELYX INC | 039697107 | COM | 278,825 | $945,216 | dollars as filed | |
| TYRA BIOSCIENCES INC | 90240B106 | COMMON STOCK | 48,170 | $820,336 | dollars as filed | |
| TRACON PHARMACEUTICALS INC | 89237H209 | COM NEW | 2,765,530 | $804,769 | dollars as filed | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 472,625 | $765,653 | dollars as filed | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 70,390 | $748,245 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 62,766 | $743,150 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 400,000 | $716,000 | dollars as filed | |
| X4 Pharmaceuticals, Inc. | 98420X103 | COM | 349,133 | $677,318 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 260,087 | $619,006 | dollars as filed | |
| FIBROGEN INC | 31572Q808 | COM | 228,420 | $616,735 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 49,031 | $565,817 | dollars as filed | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 5,472 | $557,925 | dollars as filed | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 600,000 | $528,000 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 100,000 | $516,000 | dollars as filed | |
| PROTARA THERAPEUTICS INC | 74365U107 | COM STK | 188,664 | $450,907 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 62,527 | $431,436 | dollars as filed | |
| BRAINSTORM CELL THERAPEUTICS | 10501E201 | COM | 189,935 | $391,266 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 110,600 | $363,874 | dollars as filed | call |
| ANEBULO PHARMACEUTICALS INC | 034569103 | COM | 156,203 | $340,523 | dollars as filed | |
| ELEDON PHARMACEUTICALS INC | 28617k101 | COM | 221,830 | $303,908 | dollars as filed | |
| MEREO BIOPHARMA GROUP PLC | 589492107 | CMN | 891,676 | $300,235 | dollars as filed | |
| CHEMOMAB THERAPEUTICS LTD | 16385C104 | SPONSORED ADS | 213,392 | $279,543 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 28,784 | $260,783 | dollars as filed | |
| CONNECT BIOPHARMA HLDGS LTD | 207523101 | SHS | 219,501 | $243,645 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 313,677 | $219,207 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 2,090 | $186,532 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 4,400 | $185,548 | dollars as filed | call |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 50,000 | $164,501 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 65,491 | $161,109 | dollars as filed | |
| SYNLOGIC INC | 87166L100 | COM | 306,757 | $131,905 | dollars as filed | |
| CHINOOK THERAPEUTICS INC | 16961L106 | COM | 283,464 | $130,394 | dollars as filed | |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 134,146 | $127,453 | dollars as filed | |
| FOGHORN THERAPEUTICS INC | 344174107 | COMMON STOCK | 15,000 | $105,601 | dollars as filed | |
| FINCH THERAPEUTICS GROUP INC | 31773D200 | COM NEW | 7,917 | $67,533 | dollars as filed | |
| ASLAN PHARMACEUTICALS LTD | 04522R200 | SPON ADS NEW | 164,088 | $29,813 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 75 | $17,325 | dollars as filed | |
| PHAXIAM THERAPEUTICS S A | 29604W108 | SPONSORED ADR | 3,019 | $2,257 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-001546 | this filing | 2023-08-14 | acceptance time not in the bulk data set |